Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Alpha-1-Antitrypsin (AAT)
Locations
2
United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
University of Michigan Cancer Center
Ann Arbor, Michigan, United States
Start Date
July 1, 2013
Primary Completion Date
October 1, 2016
Completion Date
October 26, 2018
Last Updated
November 27, 2018
NCT00106925
NCT06450925
NCT04337515
NCT06681922
NCT03369353
NCT03842696
Lead Sponsor
University of Michigan Rogel Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions